Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Tsuji

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Optics Express|February 1, 2024
Optical hyperdimensional soft sensing: speckle-based touch interface and tactile sensorKei Kitagawa, Kohei Tsuji, Koyo Sagehashi, et al.
Bioconjugate Chemistry|November 2, 2019
Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug ConjugatesDobeen Hwang, Kohei Tsuji, HaJeung Park, et al.
European Journal of Medicinal Chemistry|October 23, 2024
Naphthalen-1-ylethanamine-containing small molecule inhibitors of the papain-like protease of SARS-CoV-2Kouki Shinohara, Takuya Kobayakawa, Kohei Tsuji, et al.
FEBS Letters|October 29, 2013
Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitorsKosuke Tanegashima, Kohei Tsuji, Kenji Suzuki, et al.
Organic & Biomolecular Chemistry|August 2, 2021
Fluorescence resonance energy transfer-based screening for protein kinase C ligands using 6-methoxynaphthalene-labeled 1,2-diacylglycerol-lactonesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Chembiochem : a European Journal of Chemical Biology|April 24, 2025
Hybrid Molecules of Small Molecular and Peptidic HIV Fusion InhibitorsKohei Tsuji, Takuya Kobayakawa, Peter Bolah, et al.
ACS Omega|October 20, 2025
SARS-CoV‑2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene MoietiesKouki Shinohara, Takuya Kobayakawa, Kohei Tsuji, et al.
RSC Chemical Biology|September 21, 2022
Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1Kohei Tsuji, David Hymel, Buyong Ma, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.
Chembiochem : a European Journal of Chemical Biology|July 9, 2011
N-sulfanylethylanilide peptide as a crypto-thioester peptideKohei Sato, Akira Shigenaga, Kohei Tsuji, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Optics Express|February 1, 2024
Optical hyperdimensional soft sensing: speckle-based touch interface and tactile sensorKei Kitagawa, Kohei Tsuji, Koyo Sagehashi, et al.
Bioconjugate Chemistry|November 2, 2019
Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug ConjugatesDobeen Hwang, Kohei Tsuji, HaJeung Park, et al.
European Journal of Medicinal Chemistry|October 23, 2024
Naphthalen-1-ylethanamine-containing small molecule inhibitors of the papain-like protease of SARS-CoV-2Kouki Shinohara, Takuya Kobayakawa, Kohei Tsuji, et al.
FEBS Letters|October 29, 2013
Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitorsKosuke Tanegashima, Kohei Tsuji, Kenji Suzuki, et al.
Organic & Biomolecular Chemistry|August 2, 2021
Fluorescence resonance energy transfer-based screening for protein kinase C ligands using 6-methoxynaphthalene-labeled 1,2-diacylglycerol-lactonesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Chembiochem : a European Journal of Chemical Biology|April 24, 2025
Hybrid Molecules of Small Molecular and Peptidic HIV Fusion InhibitorsKohei Tsuji, Takuya Kobayakawa, Peter Bolah, et al.
ACS Omega|October 20, 2025
SARS-CoV‑2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene MoietiesKouki Shinohara, Takuya Kobayakawa, Kohei Tsuji, et al.
RSC Chemical Biology|September 21, 2022
Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1Kohei Tsuji, David Hymel, Buyong Ma, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.
Chembiochem : a European Journal of Chemical Biology|July 9, 2011
N-sulfanylethylanilide peptide as a crypto-thioester peptideKohei Sato, Akira Shigenaga, Kohei Tsuji, et al.
Pageof 7